• After the Covid pandemic, we have resumed stem cell treatments. Appropriate sterility and great care in sanitisation is undertaken as usual. If you are unwell with a cough cold or respiratory symptoms it is best to postpone your procedure.

Urology Library

Endothelial Function in ED

150 150 NZ Stem Cell Treatment Centre

2006 Sep-Oct;18(5):484-8 Circulating endothelial progenitor cells and endothelial function after chronic Tadalafil treatment in subjects with erectile dysfunction. Foresta C, Ferlin A, De Toni L, Lana A, Vinanzi C, Galan A, Caretta N. Abstract We evaluated the effect of a chronic treatment with Tadalafil on progenitor cells (PCs) number and endothelial function in patients with…

read more

Regenerative Cell Therapy

150 150 NZ Stem Cell Treatment Centre

2006 Apr;13(2):77-81. Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. Nakagami H, Morishita R, Maeda K, Kikuchi Y, Ogihara T, Kaneda Y. Abstract Adult stem cells hold great promise for use in tissue repair and regeneration, and the delivery of autologous progenitor cells into ischemic tissue is emerging as a novel…

read more

Journal of Urology

150 150 NZ Stem Cell Treatment Centre

Sept, 2005 (1045) The Effect of Neural Embryonic Stem Cell Therapy in a Rat Model of Cavernosal Nerve Injury Allen D . Seftel , M.D. ABSTRACT: Review of Bochinski article PMID: 16094049 [PubMed – indexed for MEDLINE]

read more

Erectile Dysfunction

150 150 NZ Stem Cell Treatment Centre

2005 Dec;17 Suppl 1:S57-63. Gene and stem cell therapy for erectile dysfunction. Deng W, Bivalacqua TJ, Hellstrom WJ, Kadowitz PJ Abstract Erectile dysfunction (ED) is defined as the inability to attain and/or maintain penile erection sufficient for satisfactory sexual performance. ED is a highly prevalent health problem with considerable impact on the quality of life…

read more

Erectile Function

150 150 NZ Stem Cell Treatment Centre

2005 May;47(5):710-8; discussion 718-9. Isolation of primary endothelial and stromal cell cultures of the corpus cavernosum penis for basic research and tissue engineering. Pilatz A, Schultheiss D, Gabouev AI, Schlote N, Mertsching H, Jonas U, Stief CG. Abstract OBJECTIVES: Primary cell cultures derived from the corpus cavernosum are frequently used as in vitro models to…

read more

ED & Cavernosal Tissue Function

150 150 NZ Stem Cell Treatment Centre

2004 Mar-Apr;23(2-3):167-76. Therapy of erectile dysfunction: potential future treatments. Gonzalez-Cadavid NF, Rajfer J. Abstract Current research on the development of new medical treatments of erectile dysfunction (ED) fall essentially into two main types of approaches: (1) the traditional strategy based on compounds acting to induce an erection on demand, without modifying the underlying pathologic alterations…

read more

Cavernosal Nerve Injury

150 150 NZ Stem Cell Treatment Centre

2004 Oct;94(6):904-9. Bochinski D, Lin GT, Nunes L, Carrion R, Rahman N, Lin CS, Lue TF: The effect of neural embryonic stem cell therapy in a rat model of cavernosal nerve injury. Abstract OBJECTIVE: To isolate embryonic stem cells that have differentiated along the neuronal cell line, and to assess whether injecting these neural stem…

read more

Ischemia and Enhancing Circulation

150 150 NZ Stem Cell Treatment Centre

2001 Feb 13;103(6):897-903. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Shintani S, Murohara T, Ikeda H, Ueno T, Sasaki K, Duan J, Imaizumi T. Cardiovascular Research Institute and the Department of Internal Medicine III, Kurume University School of Medicine, Kurume, Japan. Abstract BACKGROUND: Endothelial progenitor cells (EPCs) have been identified in adult human…

read more

Peyronies disease and veno-occlusive dysfunction.

150 150 NZ Stem Cell Treatment Centre

1996 Mar-Apr;17(2):96-103. Ultrastructural and immunohistochemical characterization of the tunica albuginea in Peyronie’s disease and veno-occlusive dysfunction. Gentile V, Modesti A, La Pera G, Vasaturo F, Modica A, Prigiotti G, Di Silverio F, Scarpa S. The tunica albuginea and corpus cavernosum from patients with Peyronie’s disease (PD), patients with veno-occlusive dysfunction (VOD), and those from normal…

read more

Pathology of Peyronies disease

150 150 NZ Stem Cell Treatment Centre

Nat Clin Pract Urol. 2005 Jun;2(6):291-7. Mechanisms of Disease: new insights into the cellular and molecular pathology of Peyronie’s disease. Gonzalez-Cadavid NF, Rajfer J. Peyronies disease (PD) is characterized by fibrotic plaques in the penile tunica albuginea that cause curvature of the erect penis, and is often accompanied by pain and/or erectile dysfunction. This condition…

read more